BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Resonant Therapeutics

Resonant Therapeutics logo

Founded
2016
Geography
United States of America based
Funding
$1.960 M

Developer of novel therapeutics designed to treat cancer. The Company's proprietary platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies with unprecedented speed.

Technologies

AI Companies (Drug Discovery)  

R&D Platform

Assess and prioritize a library of drug candidates derived from analyzing tumor microenvironments. Allows researchers to: Simultaneously discover novel targets and functional antibodies for cancer.


IMPaCT

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet